Lind Global Fund II LP 13D and 13G filings for InVivo Therapeutics Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:09 pm Purchase | 2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Fund II LP | 125,520 3.900% | 125,520 (New Position) | Filing |